Results 111 to 120 of about 21,895 (224)

Selective Expansion of TCR Vβ2+ Tregs and Impaired Lymphocyte TSST‐1 Responsiveness in Bullous Pemphigoid Patients Colonised by Staphylococcus aureus

Experimental Dermatology, Volume 35, Issue 9, September 2026.
ABSTRACT Bullous pemphigoid (BP) is an autoimmune blistering disease of the elderly who are frequently colonised by Staphylococcus aureus, particularly strains producing the superantigen toxic shock syndrome toxin‐1 (TSST‐1). Given the ability of TSST‐1 to engage the T cell receptor (TCR) Vβ2 chain, we investigated whether superantigen (SAg) exposure ...
Tian Y. Chen, Tyler P. Crowe, Maryam Fakhimi, Mia Poleksíc, Samuel H. Kilgore, Patrick M. Schlievert, Janet A. Fairley, Kelly N. Messingham   +7 more
wiley   +1 more source

Supplementary data for "Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid: A Distinct Disease Beyond Classic Bullous Pemphigoid"

Supplementary data for "Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid: A Distinct Disease Beyond Classic Bullous Pemphigoid", including 2 supplementary ...
Chen, Linqiao
core   +1 more source

Interventions for bullous pemphigoid (Cochrane Review).

, 2003
Bullous pemphigoid is the most common autoimmune bullous disease in the West.
Middleton, P., Wojnarowska, F., Kirtschig, G., Khumalo, N., Hollis, Sally, Murrell, D.   +5 more
core   +4 more sources

Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran

Acta Medica Iranica, 2018
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi, Maryam Daneshpazhooh, Hamidreza Mahmoudi, Maryam Nasimi, Alireza Delavari, Arghavan Azizpour   +5 more
doaj  

Blisters Don't Lie: Celiac Disease in the Skin

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
Jonas F. Ludvigsson, Philip Curman
wiley   +1 more source

Brunsting-Perry Pemphigoid of the Scalp with Antibodies against Laminin 332 [PDF]

, 2011
S. Zgažarová, Zgazarova, S., A. Niedermeier, M. Hertl, Hertl, M., H. Jedlickova, Jedlickova, H., Niedermeier, A.   +7 more
core   +1 more source

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

JEADV Clinical Practice
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy   +2 more
doaj   +1 more source

Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms

JID Innovations
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel ...
Olive C. Osuoji, Taryn DeGrazia, Robin Rolader, Emily F. Cole, Katy Lawson, Henry Hilley, Yanyan Xing, Liang Han, Sarah Chisolm, Henry Claussen, Xiaobo Yan, Yuxian Sun, Yuan Liu, Suephy C. Chen, Ron J. Feldman   +14 more
doaj   +1 more source

PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 759-761, September 2026.
Annie Jin, Katherine T. Steele, Emily Y. Chu   +2 more
wiley   +1 more source

Successful management of DPP-4 inhibitor-induced bullous pemphigoid with Stapokibart injection in an elderly diabetic patient: a case report

Frontiers in Medicine
Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as linagliptin, have been implicated in inducing bullous pemphigoid (BP) in elderly diabetic patients. Stapokibart is a humanized monoclonal antibody targeting interleukin-4 receptor subunit alpha (IL-4Rα),
Man Yu, Shue Tian, Shue Tian, Shue Tian, Fanlin Meng   +4 more
doaj   +1 more source